Adverse drug reactions to ranitidine, famotidine and omeprazole with special reference to hepatic functions and lipid profile: A prospective study

Indian Journal of Pharmacology

Volumn 29, Issue 1, 1997, Pages 20-23

  Roy, V ^a   Gupta, U ^a   Sachdev, G ^a   Bapna, J S ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

adverse drug reactions; famotidine; hepatic function tests; lipid profile; omeprazole; ranitidine

Indexed keywords

FAMOTIDINE; LIPID; OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; INDIA; LIPID METABOLISM; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRESCRIPTION; RASH;

EID: 0031050197     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 2 receptor antagonists. Aliment Pharmacol Ther 1993,7.35-40.
2. Castot A, Bidault I, Dahan R, Efthymiou ML. Evaluation of unexpected and toxic effects of omeprazole reported to the regional centres of pharmacovigilance during the first 22 post marketing months. Therapie 1993;48.469-74.
3. Enandi M, De Carli GF, Buroglio M, Recchia G. Ranitidine. seven years of drug surveillance. Clin Trials J 1988;25: 152-7
4. Grant SM. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1989;37:801-70.
5. Langtry HD, Grant SM, Goa KL. Famotidine: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1989;38:551-90.
6. McTavish D, Buckley MMT, Heel RC. Omeprazole An updated review of its pharmacology and therapeutic use in acid related disorders. Drugs 1991;42:138-70.
7. Howden CW, Fletcher CD, Farish E, Reid JL. Effects of ranitidine and cimetidine on plasma lipoproteins in healthy subjects. J Clin Pharmacol 1986;26.97-9.
8. Ooi KC, Peden NR, Champion MC, Simo EI. The effect of cimetidine and ranitidine on serum high density lipoprotein subfractions. Atherosclerosis 1985,57.159-62.
9. Terruzi V, Minoli G, Tadeo G, Nespoli M, Rossini A. The influence of cimetidine and ranitidine on the plasma lipid pattern. Br J Clin Pharmacol 1985;19:846-8.
10. Van Bommel EF, Meyboom RH. Liver damage caused by ranitidine. Ned Tijdsch Geneskd 1992;136:435-7.
11. Karachalios GS. Ranitidine and hepatitis Ann Int Med 1985;103:634-5.
12. Souza Lima MA. Hepatitis associated with ranitidine. Ann Int Med 1984,101:207-8.
13. Hiesse C, Cantarovich M, Santelli C et al. Ranitidine hepatotoxicity in renal transplant patient. Lancet 1985;1:1280.
14. Delamothe T Reporting adverse drug reactions. Br Med J 1992;304:465.
15. Bolton S (ed.) Repeated measures (split plot) designs. In: Pharmaceutical statistics, practical and clinical applications. New York and Basal: Mancel Dekker Inc., 1990:392-9.